Is it safe to preserve uterus after live birth following progestin‐based fertility‐sparing treatment for endometrial cancer or atypical hyperplasia: A long‐term retrospective cohort study
Although live birth was associated with improved recurrence-free survival in patients with EC or AEH receiving FST, postpartum recurrence remains a concern. Irregular menstruation and abnormal ultrasound findings were identified as key risk factors for recurrence, while maintenance therapy exhibited a protective effect. These findings highlight the need for vigilant postpartum monitoring in this population.
Authors
- Yifan Feng (ORCID: https://orcid.org/0000-0002-1695-9668)
- Qun Lu (ORCID: https://orcid.org/0000-0001-6025-3120)
- Linlin Bo
- Hao Wang (ORCID: https://orcid.org/0000-0001-6881-9977)
- Zerui Xiao
- R. Huang F. L. Zhou
- Yiqin Wang
- Yuanyuan Liu
- Li Tian
- Jianliu Wang
Institutions
- Capital Medical University (CN)
- Peking University (CN)
- Beijing Chao-Yang Hospital, Capital Medical University (CN)
- Peking University People's Hospital (CN)
Publication Details
- Journal
- Acta Obstetricia Et Gynecologica Scandinavica
- Published
- 2026-02-17
- DOI
- https://doi.org/10.1111/aogs.70139
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Peking University
- Peking University People's Hospital